查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1599270

动物/牲畜疫苗市场：按类型、疾病、技术分类 - 2025-2030 年全球预测

Veterinary/Animal Vaccines Market by Type (Aquaculture Vaccine, Companion Animal Vaccine, Livestock Vaccine), Disease (Aquaculture, Companion Animal, Livestock), Technology - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年动物/牲畜疫苗市值为89.6亿美元，预计2024年将达到95.8亿美元，复合年增长率为6.94%，2030年将达到143.4亿美元，预计将达到1000万美元。

动物/牲畜疫苗市场是动物保健产业的重要组成部分，重点是透过疫苗接种预防动物感染疾病。这些疫苗对于确保牲畜、宠物和野生动物的健康和生产力、支持粮食安全、公共卫生和经济效益至关重要。兽用疫苗在预防通用感染疾病、改善动物福利、减少对抗生素的依赖以及解决抗菌素抗药性问题方面的作用凸显了对兽用疫苗的需求。应用范围从牛、鸡和猪等牲畜到猫狗等伴同性动物，主要最终用途部门为牲畜、兽医医院和研究设施。

主要市场统计
基准年[2023] 89.6亿美元
预测年份 [2024] 95.8亿美元
预测年份 [2030] 143.4亿美元
复合年增长率（%） 6.94%

关键的成长要素包括对动物性蛋白质的需求增加、宠物拥有率上升以及对动物福利和疾病预防的日益关注。此外，政府促进疫苗接种的倡议以及用于开发新疫苗（例如 DNA 疫苗和重组疫苗）的生物技术进步也对市场扩张做出了重大贡献。潜在的商机来自于提高意识和对研发的投资，旨在创造更有效、负担得起且易于管理的疫苗。利用这些机会的研究包括投资创新研究、加强分销网络以及关注都市化和可支配收入不断提高的新兴市场。

然而，严格的监管要求、疫苗市场开拓的高成本以及某些地区缺乏意识等挑战正在阻碍市场成长。稳定性和储存问题，加上新兴经济体有限的低温运输，也是主要障碍。所需的创新和研究领域包括开发耐热疫苗、口服疫苗和奈米颗粒疫苗等替代递送系统，以及增强免疫反应的新型佐剂。了解竞争格局、监管格局和消费者偏好对于寻求发展的企业至关重要。市场往往是动态的，不断的技术创新和监管变化塑造着市场的演变，带来挑战和新的成长机会。

市场动态：快速发展的兽药/牲畜疫苗市场的关键市场洞察

供需的动态交互作用正在改变动物/牲畜疫苗市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 饲养的伴同性动物和牲畜数量增加
    • 改善经济国家的兽医医疗设施
    • 动物慢性病和意外伤害发生率增加
  • 市场限制因素
    • 疫苗储存成本高
  • 市场机会
    • 加大兽用疫苗研发投入
    • 增加宠物保险的可用性
  • 市场挑战
    • 监测和报告系统不足

波特的五力战略工具驾驭动物/牲畜疫苗市场

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解兽用/牲畜疫苗市场的外部影响

外部宏观环境因素在塑造动物/家畜疫苗市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解动物/牲畜疫苗市场的竞争状况

动物/牲畜疫苗市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵兽医/牲畜疫苗市场供应商的绩效评估

FPNV 定位矩阵是评估动物/牲畜疫苗市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了兽药/牲畜疫苗市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对动物/牲畜疫苗市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 饲养宠物和牲畜的数量增加
      • 改善经济中的兽医护理设施
      • 动物慢性病和意外伤害发生率增加
    • 抑制因素
      • 疫苗储存成本高
    • 机会
      • 加大兽用疫苗研发投入
      • 扩大宠物保险的保障范围
    • 任务
      • 监测和报告系统不足
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章动物/牲畜疫苗市场：依类型

  • 水产养殖疫苗
  • 宠物疫苗
  • 牲畜疫苗
  • 猪疫苗
  • 家禽疫苗

第七章动物/牲畜疫苗市场：依疾病分类

  • 水产养殖
  • 宠物
  • 家畜
  • 猪肉
  • 家禽

第八章动物/牲畜疫苗市场：依技术分类

  • 灭活疫苗
  • 减毒活疫苗
  • 重组疫苗
  • 类毒素疫苗

第九章美洲动物/牲畜疫苗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太动物/牲畜疫苗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲/中东/非洲动物/家畜疫苗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Aptimmune Biologics, Inc.
  • Biogenesis Bago SA
  • Boehringer Ingelheim International GmbH
  • Brilliant Bio Pharma Private Limited
  • Ceva Sante Animale
  • China Animal Husbandry Industry Co., Ltd
  • Elanco AB
  • Endovac Animal Health
  • Heska Corporation
  • Hester Biosciences Limited
  • HIPRA, SA
  • IDT Biologika GmbH
  • Indian Immunologicals Ltd.
  • Merck & Co., Inc.
  • Phibro Animal Health Corporation
  • Torigen Pharmaceuticals Inc.
  • Virbac SA
  • Zoetis Inc.
Product Code: MRR-034B500303A8

The Veterinary/Animal Vaccines Market was valued at USD 8.96 billion in 2023, expected to reach USD 9.58 billion in 2024, and is projected to grow at a CAGR of 6.94%, to USD 14.34 billion by 2030.

The veterinary/animal vaccines market is a crucial segment within the larger animal healthcare industry, focused on preventing infectious diseases among animals through immunization. These vaccines are essential for ensuring the health and productivity of livestock, pets, and wildlife, thus supporting food security, public health, and economic interest. The necessity of animal vaccines is underscored by their role in preventing zoonotic diseases, enhancing animal welfare, and decreasing the reliance on antibiotics, which aids in addressing antimicrobial resistance concerns. Application spans from livestock such as cattle, poultry, and swine to companion animals like cats and dogs, with their primary end-use sectors being animal husbandry, veterinary clinics, and research facilities.

KEY MARKET STATISTICS
Base Year [2023] USD 8.96 billion
Estimated Year [2024] USD 9.58 billion
Forecast Year [2030] USD 14.34 billion
CAGR (%) 6.94%

Key growth factors include increasing demand for animal protein, rising pet ownership, and a heightened focus on animal welfare and disease prevention. Additionally, government initiatives to promote vaccination and advancements in biotechnology for developing novel vaccines like DNA or recombinant vaccines contribute significantly to market expansion. Potential opportunities arise from the growing awareness and investment in research and development, aiming to create more effective, affordable, and easily administrable vaccines. Recommendations to capitalize on these opportunities include investing in innovative research, enhancing distribution networks, and focusing on emerging markets with increasing urbanization and disposable incomes.

However, market growth is challenged by factors like stringent regulatory requirements, high costs associated with vaccine development, and a lack of awareness in certain regions. Stability and storage issues, coupled with limited cold chain infrastructure in developing economies, also pose significant barriers. Areas ripe for innovation and research include developing thermostable vaccines, alternative delivery systems such as oral or nanoparticle-based vaccines, and novel adjuvants to enhance immune responses. Understanding the competitive and regulatory landscape, along with consumer preferences, is critical for businesses aiming for growth. The market tends to be dynamic, with continuous innovations and regulatory changes shaping its evolution and presenting both challenges and novel growth opportunities.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Veterinary/Animal Vaccines Market

The Veterinary/Animal Vaccines Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing number of companion animal and livestock ownership
    • Improving veterinary care facilities in economies
    • Rising incidence of chronic diseases and accidental injuries in animals
  • Market Restraints
    • High storage costs for vaccines
  • Market Opportunities
    • Rising investments in veterinary vaccine R&D
    • Growing availability of pet insurance
  • Market Challenges
    • Inadequate surveillance and reporting systems

Porter's Five Forces: A Strategic Tool for Navigating the Veterinary/Animal Vaccines Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Veterinary/Animal Vaccines Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Veterinary/Animal Vaccines Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Veterinary/Animal Vaccines Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Veterinary/Animal Vaccines Market

A detailed market share analysis in the Veterinary/Animal Vaccines Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Veterinary/Animal Vaccines Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Veterinary/Animal Vaccines Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Veterinary/Animal Vaccines Market

A strategic analysis of the Veterinary/Animal Vaccines Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Veterinary/Animal Vaccines Market, highlighting leading vendors and their innovative profiles. These include Aptimmune Biologics, Inc., Biogenesis Bago SA, Boehringer Ingelheim International GmbH, Brilliant Bio Pharma Private Limited, Ceva Sante Animale, China Animal Husbandry Industry Co., Ltd, Elanco AB, Endovac Animal Health, Heska Corporation, Hester Biosciences Limited, HIPRA, S.A., IDT Biologika GmbH, Indian Immunologicals Ltd., Merck & Co., Inc., Phibro Animal Health Corporation, Torigen Pharmaceuticals Inc., Virbac SA, and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Veterinary/Animal Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Aquaculture Vaccine, Companion Animal Vaccine, Livestock Vaccine, Porcine Vaccine, and Poultry Vaccine.
  • Based on Disease, market is studied across Aquaculture, Companion Animal, Livestock, Porcine, and Poultry.
  • Based on Technology, market is studied across Inactivated Vaccine, Live Attenuated Vaccine, Recombinant Vaccine, and Toxoid Vaccine.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing number of companion animal and livestock ownership
      • 5.1.1.2. Improving veterinary care facilities in economies
      • 5.1.1.3. Rising incidence of chronic diseases and accidental injuries in animals
    • 5.1.2. Restraints
      • 5.1.2.1. High storage costs for vaccines
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising investments in veterinary vaccine R&D
      • 5.1.3.2. Growing availability of pet insurance
    • 5.1.4. Challenges
      • 5.1.4.1. Inadequate surveillance and reporting systems
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Veterinary/Animal Vaccines Market, by Type

  • 6.1. Introduction
  • 6.2. Aquaculture Vaccine
  • 6.3. Companion Animal Vaccine
  • 6.4. Livestock Vaccine
  • 6.5. Porcine Vaccine
  • 6.6. Poultry Vaccine

7. Veterinary/Animal Vaccines Market, by Disease

  • 7.1. Introduction
  • 7.2. Aquaculture
  • 7.3. Companion Animal
  • 7.4. Livestock
  • 7.5. Porcine
  • 7.6. Poultry

8. Veterinary/Animal Vaccines Market, by Technology

  • 8.1. Introduction
  • 8.2. Inactivated Vaccine
  • 8.3. Live Attenuated Vaccine
  • 8.4. Recombinant Vaccine
  • 8.5. Toxoid Vaccine

9. Americas Veterinary/Animal Vaccines Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Veterinary/Animal Vaccines Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Veterinary/Animal Vaccines Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aptimmune Biologics, Inc.
  • 2. Biogenesis Bago SA
  • 3. Boehringer Ingelheim International GmbH
  • 4. Brilliant Bio Pharma Private Limited
  • 5. Ceva Sante Animale
  • 6. China Animal Husbandry Industry Co., Ltd
  • 7. Elanco AB
  • 8. Endovac Animal Health
  • 9. Heska Corporation
  • 10. Hester Biosciences Limited
  • 11. HIPRA, S.A.
  • 12. IDT Biologika GmbH
  • 13. Indian Immunologicals Ltd.
  • 14. Merck & Co., Inc.
  • 15. Phibro Animal Health Corporation
  • 16. Torigen Pharmaceuticals Inc.
  • 17. Virbac SA
  • 18. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. VETERINARY/ANIMAL VACCINES MARKET RESEARCH PROCESS
  • FIGURE 2. VETERINARY/ANIMAL VACCINES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. VETERINARY/ANIMAL VACCINES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. VETERINARY/ANIMAL VACCINES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VETERINARY/ANIMAL VACCINES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. VETERINARY/ANIMAL VACCINES MARKET DYNAMICS
  • TABLE 7. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY AQUACULTURE VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMAL VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY PORCINE VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY POULTRY VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY AQUACULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COMPANION ANIMAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY PORCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY INACTIVATED VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY RECOMBINANT VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TOXOID VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 56. INDIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 59. INDONESIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 62. JAPAN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 65. MALAYSIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 68. PHILIPPINES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 71. SINGAPORE VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 74. SOUTH KOREA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 77. TAIWAN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 80. THAILAND VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 83. VIETNAM VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 90. DENMARK VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 93. EGYPT VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 96. FINLAND VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 99. FRANCE VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 102. GERMANY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 105. ISRAEL VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 108. ITALY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 111. NETHERLANDS VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 114. NIGERIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 117. NORWAY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 120. POLAND VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 123. QATAR VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 126. RUSSIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 129. SAUDI ARABIA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH AFRICA VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 135. SPAIN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 138. SWEDEN VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 141. SWITZERLAND VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 144. TURKEY VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED ARAB EMIRATES VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM VETERINARY/ANIMAL VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED KINGDOM VETERINARY/ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. VETERINARY/ANIMAL VACCINES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 152. VETERINARY/ANIMAL VACCINES MARKET, FPNV POSITIONING MATRIX, 2023